Contact this trialFirst, we need to learn more about you.
FAZA PET/MRI Scan for Gastroesophageal Cancer
Recruiting1 award4 criteria
Toronto, Ontario
This trial will test if using PET/MRI with the radiotracer 18F-Fluoroazomycin Arabinoside (FAZA) can help predict how well a patient with metastatic Gastro-Oesophageal Cancer will respond to platinum-based chemotherapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.